Comparable Liraglutide Pharmacokinetics in Pediatric and Adult Populations with Type 2 Diabetes: A Population Pharmacokinetic Analysis

BACKGROUND AND OBJECTIVE: The safety, tolerability, and pharmacokinetics of the once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide have been evaluated in pediatric patients aged greater than 10 years with type 2 diabetes (T2D). In this study, a population pharmacokinetic analysis wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Petri, Kristin C. Carlsson, Jacobsen, Lisbeth V., Klein, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449373/
https://www.ncbi.nlm.nih.gov/pubmed/25603819
http://dx.doi.org/10.1007/s40262-014-0229-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449373/
https://www.ncbi.nlm.nih.gov/pubmed/25603819
http://dx.doi.org/10.1007/s40262-014-0229-z

Ejemplares similares